Abbott to Present at Morgan Stanley Global Healthcare Conference

ABBOTT PARK, Ill., Aug. 31, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 13, 2011. John Leonard, M.D., senior vice president, pharmaceuticals, research and development, will participate in a 30-minute discussion about the company beginning at 10:30 a.m. Central time.

A live audio webcast will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com.  An archived edition of the presentation will be available later that day.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.  

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

SOURCE Abbott

Suggested Articles

The Trump administration has selected five COVID-19 vaccines for Operation Warp Speed, the NYT reports, with Big Pharma dominating the list.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

Bristol Myers Squibb's Zeposia will leverage promising top-line phase 3 data into a possible FDA approval in the lucrative ulcerative colitis market.